PR Newswire: news distribution, targeting and monitoring
2013
See more news releases in Banking & Financial Services  | Legal Issues

Faruqi & Faruqi, LLP Files Class Action Lawsuit Against AEterna Zentaris Inc. - AEZS

Share with Twitter Share with LinkedIn

NEW YORK, June 15, 2012 /PRNewswire/ -- Notice is hereby given that Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the Southern District of New York, Case No. 12-Civ-4711, on behalf of all persons who purchased AEterna Zentaris Inc. ("AEterna" or the "Company") (NASDAQ GM: AEZS) securities between February 3, 2010 and April 1, 2012 inclusive (the "Class Period").

(Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO)

If you wish to obtain information concerning this action or view a copy of the complaint, you can do so by clicking here: http://faruqilaw.com/AEZS. There is no cost or obligation to you.

AEterna, AEterna's Chief Executive Officer Juergen Engel and AEterna's Chief Financial Officer Dennis Turpin are charged with violations of Section 10(b) and/or 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.  Specifically, the complaint alleges that defendants mislead investors about the timing and success of AEterna's clinical trial that tested whether the drug perifosine was effective in treating late stage colorectal cancer. 

On April 2, 2012, AEterna shocked the market by disclosing that perifosine was ineffective in treating colorectal cancer.  This news caused AEterna stock to drop approximately 66% by the close of the business day. 

Plaintiff now seeks to recover damages on behalf of himself and all other individual and institutional investors who bought AEterna securities between February 3, 2010 and April 1, 2012, excluding defendants and their affiliates.  Plaintiff is represented by Faruqi & Faruqi, LLP, a law firm with extensive experience in prosecuting class actions and actions involving corporate fraud.

If you purchased AEterna securities during the Class Period, you may, not later than August 14, 2012, move the court to serve as lead plaintiff of the class, if you so choose.  In order to discuss this action, or if you have any questions concerning this notice or your rights or interests, please contact:

Faruqi & Faruqi, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
ATTN: Juan Monteverde, Esq , Richard Gonnello, Esq. or Francis P. McConville, Esq.
jmonteverde@faruqilaw.com, rgonnello@faruqilaw.com or fmcconville@faruqilaw.com
Toll Free: (877) 247-4292
Phone: (212) 983-9330

Attorney Advertising. (C) 2012 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

SOURCE Faruqi & Faruqi, LLP



RELATED LINKS
http://www.faruqilaw.com

Featured Video

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

Share with Twitter Share with LinkedIn
 

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

 
 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

 
 

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.

 
Advanced Search
Search
  
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire